Literature DB >> 17697954

On risks and benefits of iron supplementation recommendations for iron intake revisited.

Klaus Schümann1, Thomas Ettle, Bernadett Szegner, Bernd Elsenhans, Noel W Solomons.   

Abstract

Iron is an essential trace element with a high prevalence of deficiency in infants and in women of reproductive age from developing countries. Iron deficiency is frequently associated with anaemia and, thus, with reduced working capacity and impaired intellectual development. Moreover, the risk for premature delivery, stillbirth and impaired host-defence is increased in iron deficiency. Iron-absorption and -distribution are homeostatically regulated to reduce the risk for deficiency and overload. These mechanisms interact, in part, with the mechanisms of oxidative stress and inflammation and with iron availability to pathogens. In the plasma, fractions of iron may not be bound to transferrin and are hypothesised to participate in atherogenesis. Repleted iron stores and preceding high iron intakes reduce intestinal iron absorption which, however, offers no reliable protection against oral iron overload. Recommendations for dietary iron intake at different life stages are given by the US Food and Nutrition Board (FNB), by FAO/WHO and by the EU Scientific Committee, among others. They are based, on estimates for iron-losses, iron-bioavailability from the diet, and iron-requirements for metabolism and growth. Differences in choice and interpretation of these estimates lead to different recommendations by the different panels which are discussed in detail. Assessment of iron-related risks is based on reports of adverse health effects which were used in the attempts to derive an upper safe level for dietary iron intake. Iron-related harm can be due to direct intestinal damage, to oxidative stress, or to stimulated growth of pathogens. Unfortunately, it is problematic to derive a reproducible cause-effect and dose-response relationship for adverse health effects that suggest a relationship to iron-intake, be they based on mechanistic or epidemiological observations. Corresponding data and interpretations are discussed for the intestinal lumen, the vascular system and for the intracellular and interstitial space, considering interference of the mechanisms of iron homoeostasis as a likely explanation for differences in epidemiological observations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697954     DOI: 10.1016/j.jtemb.2007.06.002

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  24 in total

1.  Supplementation with a dietary multicomponent (Lafergin(®)) based on Ferric Sodium EDTA (Ferrazone(®)): results of an observational study.

Authors:  Pietro Cignini; Lucia Mangiafico; Francesco Padula; Laura D'Emidio; Nella Dugo; Alessia Aloisi; Claudio Giorlandino; Salvatore Giovanni Vitale
Journal:  J Prenat Med       Date:  2015 Jan-Jun

2.  Neurocognitive Function Is Associated With Serum Iron Status in Early Adolescents.

Authors:  Xiaopeng Ji; Naixue Cui; Jianghong Liu
Journal:  Biol Res Nurs       Date:  2017-02-15       Impact factor: 2.522

3.  Complementary food with low (8%) or high (12%) meat content as source of dietary iron: a double-blinded randomized controlled trial.

Authors:  Katharina Dube; Jana Schwartz; Manfred J Mueller; Hermann Kalhoff; Mathilde Kersting
Journal:  Eur J Nutr       Date:  2009-07-19       Impact factor: 5.614

Review 4.  Iron Deficiency, Cognitive Functions, and Neurobehavioral Disorders in Children.

Authors:  Lyudmila Pivina; Yuliya Semenova; Monica Daniela Doşa; Marzhan Dauletyarova; Geir Bjørklund
Journal:  J Mol Neurosci       Date:  2019-02-18       Impact factor: 3.444

5.  Anti-anaemia efficacy of β-lactoglobulin hydrolysate-iron complex on iron-deficient anaemic rats.

Authors:  Jie Zhou; Xue-Ying Mao; Xu Wang; Ting Ai; Jing-Jiao Ma; Ying-Hui Li
Journal:  Eur J Nutr       Date:  2013-10-06       Impact factor: 5.614

Review 6.  Body iron delocalization: the serious drawback in iron disorders in both developing and developed countries.

Authors:  R Paesano; T Natalizi; F Berlutti; P Valenti
Journal:  Pathog Glob Health       Date:  2012-08       Impact factor: 2.894

7.  Cachexia and aging: an update based on the Fourth International Cachexia Meeting.

Authors:  J E Morley; S D Anker; W J Evans
Journal:  J Nutr Health Aging       Date:  2009-01       Impact factor: 4.075

Review 8.  Daily oral iron supplementation during pregnancy.

Authors:  Juan Pablo Peña-Rosas; Luz Maria De-Regil; Maria N Garcia-Casal; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

Review 9.  Daily oral iron supplementation during pregnancy.

Authors:  Juan Pablo Peña-Rosas; Luz Maria De-Regil; Therese Dowswell; Fernando E Viteri
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

10.  Baseline Hemoglobin, Hepcidin, Ferritin, and Total Body Iron Stores are Equally Strong Diagnostic Predictors of a Hemoglobin Response to 12 Weeks of Daily Iron Supplementation in Cambodian Women.

Authors:  Lulu X Pei; Hou Kroeun; Suzanne M Vercauteren; Susan I Barr; Tim J Green; Arianne Y Albert; Crystal D Karakochuk
Journal:  J Nutr       Date:  2021-08-07       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.